POLQ inhibition represents a synthetic lethal approach to blocking tumor growth while concurrently activating the cGAS-STING signaling pathway, enhancing tumor immune infiltration and offering a novel therapeutic strategy [81]. Here, CGAS is linked to neoplasm.